gene therapy

Astellas becomes latest Dyno gene therapy partner with $1.6B biobucks pact to join Roche, Novartis, Sarepta
Fierce Biotech
Wed, 12/1/21 - 11:51 pm
Astellas
Dyno Therapeutics
biobucks
gene therapy
Speed, flexibility and innovation: Rethinking the way biopharma industry operates
Biopharma Reporter
Mon, 11/29/21 - 10:39 pm
innovation
speed-to-market
gene therapy
cell therapy
supply chain
Bluebird bio may finally get a gene therapy approved in the US
Endpoints
Mon, 11/22/21 - 10:28 am
Bluebird Bio
gene therapy
FDA
Zynteglo
beta-thalassemia
priority review
Parkinson's gene therapy restores responses to dopamine-boosting drug in mouse models
Fierce Biotech
Fri, 11/5/21 - 09:49 am
Parkinson's Disease
Levodopa
gene therapy
Voyager Therapeutics
Bayer
Sangamo's Fabry gene therapy clears early clinical test, firing starting gun on preparations for phase 3
Fierce Biotech
Thu, 11/4/21 - 10:48 am
Sangamo Therapeutics
Fabry disease
gene therapy
clinical trials
ST-920
Pfizer tears up gene therapy timelines, revealing a series of phase 3 delays that end vision of a banner 2022
Fierce Biotech
Wed, 11/3/21 - 10:43 am
Pfizer
gene therapy
hemophilia
Duchenne Muscular Dystrophy
Sangamo Therapeutics
GenScript embraces automation at its first cell, gene therapy manufacturing US site
Fierce Pharma
Tue, 11/2/21 - 11:53 pm
GenScript
gene therapy
CDMOs
drug manufacturing
Global Blood takes on gene therapy
EP Vantage
Thu, 10/28/21 - 10:36 am
Global Blood Therapeutics
GBT021601
Oxbryta
gene therapy
ASH2021
sickle cell disease
FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases
FDA
Wed, 10/27/21 - 11:49 pm
Bespoke Gene Therapy Consortium
NIH
FDA
gene therapy
ElevateBio cuts a deal for Life Edit, adding genome engineering tech to support gene therapy pipeline
Fierce Biotech
Wed, 10/27/21 - 11:05 am
Elevate Bio
Life Edit Therapeutics
gene therapy
genome editing
M&A
Novartis dumps Rett gene therapy caught up in Zolgensma scandal in cull of pipeline prospects
Fierce Biotech
Tue, 10/26/21 - 10:41 am
Novartis
Rett Syndrome
AVXS-201
Zolgensma
gene therapy
Bluebird, winding down in Europe, withdraws another rare disease gene therapy
BioPharma Dive
Thu, 10/21/21 - 11:17 pm
Bluebird Bio
gene therapy
Europe
Skysona
cerebral adrenoleukodystrophy
A California biotech steps into the viral vector space with new site build of $75M
Endpoints
Thu, 10/14/21 - 10:58 am
Avid Bioservices
cell therapy
gene therapy
California
CDMOs
Charles River Laboratories has been on an acquisition spree. But Tuesday, it offloaded two assets
Endpoints
Wed, 10/13/21 - 10:53 am
Charles River Laboratories
M&A
gene therapy
CDMOs
Poseida, Takeda partner to develop eight in vivo gene therapy programs
Pharmaceutical Business Review
Wed, 10/13/21 - 10:51 am
Takeda
Poseida Therapeutics
gene therapy
drug development
Sarepta outlines final push for Duchenne gene therapy
BioPharma Dive
Mon, 10/11/21 - 09:52 pm
Sarepta Therapeutics
gene therapy
Duchenne Muscular Dystrophy
clinical trials
Pfizer agrees $630m deal to harness Voyager’s gene therapy tech
Pharmaforum
Wed, 10/6/21 - 10:46 am
Pfizer
Voyager Therapeutics
gene therapy
Gemini axes CSO and 20% of staff to focus on late-phase plans
Fierce Biotech
Tue, 10/5/21 - 10:43 am
Gemini Therapeutics
layoffs
gene therapy
CSO
age-related macular degeneration
Takeda taps Selecta for $1.1B gene therapy research pact
Fierce Biotech
Mon, 10/4/21 - 10:43 am
Takeda
Selecta Biosciences
gene therapy
biobucks
Philadelphia Bursting at the Seams as Biopharma Hub Status Grows
BioSpace
Sun, 10/3/21 - 08:19 pm
Philadelphia
cell therapy
gene therapy
biotech hubs

Pages